genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2010
Osteosarcoma
News
Bioniche Earns $4M Milestone from Endo following Positive Phase III Urocidin Data
Drug Discovery
Scancell Gains Rights to mAb from CRT for Immunotherapy Development
Cancer
Canine Cancer Consortium Hopes to Generate Insights for Rare Human Sarcomas
Cancer
TopoTarget Earns $30M Up Front in Deal with Spectrum for Late-Stage Anticancer Agent
News
Spectrum Ditches Mid-Stage BPH Therapy
Industry News
Spectrum Pockets $47.5M in Registered Direct Offering
Industry News
Takeda to Acquire IDM Pharma for $66.7M
News
IDM Pharma’s Osteosarcoma Drug Fails to Win FDA Approval
1
2
Page 2 of 2
Scroll Up